You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

FLUDARA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Fludara, and what generic alternatives are available?

Fludara is a drug marketed by Genzyme Corp, Actavis Llc, Actavis Totowa, Areva Pharms, Fresenius Kabi Usa, Hikma, Hospira, Mylan Labs Ltd, Sagent Pharms Inc, and Sandoz. and is included in twelve NDAs.

The generic ingredient in FLUDARA is fludarabine phosphate. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the fludarabine phosphate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Fludara

A generic version of FLUDARA was approved as fludarabine phosphate by HIKMA on August 28th, 2003.

  Try a Trial

Drug patent expirations by year for FLUDARA
Drug Prices for FLUDARA

See drug prices for FLUDARA

Recent Clinical Trials for FLUDARA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
SanofiPhase 1
Center for International Blood and Marrow Transplant ResearchPhase 1/Phase 2
Eugia Pharma Specialities LimitedPhase 1

See all FLUDARA clinical trials

US Patents and Regulatory Information for FLUDARA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genzyme Corp FLUDARA fludarabine phosphate INJECTABLE;INJECTION 020038-001 Apr 18, 1991 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hikma FLUDARABINE PHOSPHATE fludarabine phosphate INJECTABLE;INJECTION 076349-001 Aug 28, 2003 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Areva Pharms FLUDARABINE PHOSPHATE fludarabine phosphate INJECTABLE;INJECTION 090724-001 Sep 27, 2010 AP1 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.